US Stocks Slide as S&P 500 and Nasdaq Weaken Under Pressure from Alphabet and Tech Giants Amid Iran Tensions.

The S&P 500 and Nasdaq Composite indexes experienced declines on Monday, primarily driven by significant drops in key technology stocks, including Alphabet, as investors remain cautious amid evolving geopolitical tensions in U.S.-Iran negotiations. The S&P 500 closed down 0.34%, while the Nasdaq slipped by 1.28%. In contrast, the Dow Jones Industrial Average recorded modest gains, buoyed by strength in the healthcare and industrial sectors, reflecting a mixed market response to prevailing economic signals.

SpaceX’s recent foray into debt financing, coupled with reported cash reserves of $100.8 billion, contributed to the downward pressure on the Nasdaq, indicating a volatile sentiment within the tech sector. Despite recent optimism surrounding artificial intelligence, concerns over escalating expenditures on infrastructure by major hyperscalers have surfaced, leading analysts to question the sustainability of current stock valuations in this segment. Continued focus on the fundamentals, particularly in AI-driven data center expansions, may foster a more grounded approach among investors.

Market dynamics are further complicated by geopolitical developments, particularly the potential for a resolution in U.S.-Iran discussions, which have resulted in declining oil prices—an environment that may benefit both consumers and businesses. However, the recent shift towards a more hawkish Federal Reserve under newly appointed Chair Kevin Warsh has injected uncertainty into the market outlook, as rising Treasury yields correlate with heightened stock market volatility. The impending Personal Consumption Expenditures (PCE) data release on Thursday will be critical in shaping investor expectations for future monetary policies.

Additionally, Micron Technology’s upcoming quarterly results are anticipated to serve as a crucial benchmark, particularly given the company’s remarkable year-to-date performance. Positive trends among select biotech firms, such as Apogee Therapeutics’ surge following AbbVie’s acquisition announcement, also highlight sector-specific opportunities counterbalancing broader market headwinds. Investors are advised to remain vigilant as they navigate both macroeconomic indicators and sector-specific developments that may influence market trajectories in the near term.

Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova team.)